Projects highlighted are not comprehensive of all IEF projects. Markers are an estimate of project location.
Development of EEHV-specific nanobodies as treatment for EEHV-hemorrhagic diseaseNicole Zeiler2023-04-08T20:18:42+00:00
Development of EEHV-specific Nanobodies as Treatment for EEHV-hemorrhagic Disease
Elephant Endotheliotropic Herpesviruses (EEHV) are a group of elephant-specific viruses that may cause acute, highly lethal haemorrhagic disease in young elephants. Building upon previous work that developed a set of EEHV-specific nanobodies, this project seeks to identify EEHV-neutralizing nanobodies to be used as future prophylaxis or treatment.
Project Years: 2023
Project Partners: Utrecht University, The Netherlands